國立虎尾科技大學 |

Coronavirus Therapeutics – Volume I = Basic Science and Therapy Development /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Coronavirus Therapeutics – Volume I/ edited by Alexzander A. A. Asea, Punit Kaur.
其他題名:	Basic Science and Therapy Development /
其他作者:	Kaur, Punit.
面頁冊數:	IX, 222 p. 1 illus.online resource. :
Contained By:	Springer Nature eBook
標題:	Clinical Research. -
電子資源:	https://doi.org/10.1007/978-3-030-85109-5
ISBN:	9783030851095

Coronavirus Therapeutics – Volume I = Basic Science and Therapy Development /
Coronavirus Therapeutics – Volume IBasic Science and Therapy Development /[electronic resource] :edited by Alexzander A. A. Asea, Punit Kaur. - 1st ed. 2021. - IX, 222 p. 1 illus.online resource. - Advances in Experimental Medicine and Biology,13522214-8019 ;. - Advances in Experimental Medicine and Biology,889.

Origin and structural biology of Novel Coronavirus (SARS-CoV-2) -- The Molecular Virology of Coronaviruses with Special Reference to SARS-CoV-2 -- Epidemiology, transmission and molecular immunopathology of SARS-CoV-2 -- Epidemiology and Etiopathogeny of Covid-19 -- Immunological and Hematological Response in COVID-19 -- Toll-like receptors (TLRs) as Therapeutic Targets for Treating SARS-CoV-2: An Immunobiological Perspective -- Potential drug strategies to target Coronaviruses -- Possible therapeutic intervention strategies for COVID-19 by manipulating the cellular proteostasis network -- The potential impact of statins in the treatment of patients with COVID-19 infection -- Anticoronavirus activity of water-soluble pristine C60 fullerenes: in vitro and in silico screening -- Application of Nanoscale materials and nanotechnology against viral infection: A special focus on Coronaviruses -- Obesity: A Risk Factor for Covid-19 -- Cytokine Storm and Failed Resolution in COVID-19: Taking Cue from Multiple Sclerosis.

The book Coronavirus Therapeutics Volume I provides the most comprehensive review on contemporary knowledge on the origin, structural biology and molecular aspects of Coronaviruses. It also describes the etiology and pathogeny and therapeutic targets including vaccine drug candidates against Coronaviruses in the light of current scientific knowledge. Using an integrative approach to the understanding of Coronaviruses structure, function and immunobiology, the contributors provide a synopsis of novel mechanisms by which Coronaviruses can be treated. Key basic and clinical research laboratories from major universities, academic medical hospitals, biotechnology and pharmaceutical laboratories around the world have contributed articles that review present research activity on the role of heat shock proteins in human diseases and importantly project the field into the future. The book is a must read for graduate students. medical students, basic science researchers and postdoctoral scholars in the fields of Cancer Biology, Oncology, Cardiovascular Diseases, Microbiology, Inflammation, Translational Medicine, Clinical Research, Biotechnology, Cell & Molecular Medicine, Pharmaceutical Scientists and Researchers involved in Drug Discovery.

ISBN: 9783030851095

Standard No.: 10.1007/978-3-030-85109-5doiSubjects--Topical Terms:

1366605
Clinical Research.

LC Class. No.: R850.A1-854

Dewey Class. No.: 610.72

Coronavirus Therapeutics – Volume I = Basic Science and Therapy Development /
LDR:03783nam a22004215i 4500 001 1059891
003 DE-He213
005 20220207174921.0
007 cr nn 008mamaa
008 220414s2021 sz | s |||| 0|eng d
020 $a 9783030851095 $9 978-3-030-85109-5
024 7 $a 10.1007/978-3-030-85109-5 $2 doi
035 $a 978-3-030-85109-5
050 4 $a R850.A1-854
050 4 $a QH315-320
072 7 $a MBGR $2 bicssc
072 7 $a MED000000 $2 bisacsh
072 7 $a MBGR $2 thema
082 0 4 $a 610.72 $2 23
245 1 0 $a Coronavirus Therapeutics – Volume I $h [electronic resource] : $b Basic Science and Therapy Development / $c edited by Alexzander A. A. Asea, Punit Kaur.
250 $a 1st ed. 2021.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2021.
300 $a IX, 222 p. 1 illus. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Advances in Experimental Medicine and Biology, $x 2214-8019 ; $v 1352
505 0 $a Origin and structural biology of Novel Coronavirus (SARS-CoV-2) -- The Molecular Virology of Coronaviruses with Special Reference to SARS-CoV-2 -- Epidemiology, transmission and molecular immunopathology of SARS-CoV-2 -- Epidemiology and Etiopathogeny of Covid-19 -- Immunological and Hematological Response in COVID-19 -- Toll-like receptors (TLRs) as Therapeutic Targets for Treating SARS-CoV-2: An Immunobiological Perspective -- Potential drug strategies to target Coronaviruses -- Possible therapeutic intervention strategies for COVID-19 by manipulating the cellular proteostasis network -- The potential impact of statins in the treatment of patients with COVID-19 infection -- Anticoronavirus activity of water-soluble pristine C60 fullerenes: in vitro and in silico screening -- Application of Nanoscale materials and nanotechnology against viral infection: A special focus on Coronaviruses -- Obesity: A Risk Factor for Covid-19 -- Cytokine Storm and Failed Resolution in COVID-19: Taking Cue from Multiple Sclerosis.
520 $a The book Coronavirus Therapeutics Volume I provides the most comprehensive review on contemporary knowledge on the origin, structural biology and molecular aspects of Coronaviruses. It also describes the etiology and pathogeny and therapeutic targets including vaccine drug candidates against Coronaviruses in the light of current scientific knowledge. Using an integrative approach to the understanding of Coronaviruses structure, function and immunobiology, the contributors provide a synopsis of novel mechanisms by which Coronaviruses can be treated. Key basic and clinical research laboratories from major universities, academic medical hospitals, biotechnology and pharmaceutical laboratories around the world have contributed articles that review present research activity on the role of heat shock proteins in human diseases and importantly project the field into the future. The book is a must read for graduate students. medical students, basic science researchers and postdoctoral scholars in the fields of Cancer Biology, Oncology, Cardiovascular Diseases, Microbiology, Inflammation, Translational Medicine, Clinical Research, Biotechnology, Cell & Molecular Medicine, Pharmaceutical Scientists and Researchers involved in Drug Discovery.
650 2 4 $a Clinical Research. $3 1366605
650 1 4 $a Biomedical Research. $3 643481
650 0 $a Epidemiology. $3 635923
650 0 $a Clinical medicine—Research. $3 1366604
650 0 $a Virology. $3 644995
650 0 $a Biology—Research. $3 1365799
650 0 $a Medicine—Research. $3 1365798
700 1 $a Kaur, Punit. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1115285
700 1 $a Asea, Alexzander A. A. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1115284
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030851088
776 0 8 $i Printed edition: $z 9783030851101
776 0 8 $i Printed edition: $z 9783030851118
830 0 $a Advances in Experimental Medicine and Biology, $x 0065-2598 ; $v 889 $3 1253792
856 4 0 $u https://doi.org/10.1007/978-3-030-85109-5
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)